Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons

Journal of Neuroscience Research

Volumn 53, Issue 3, 1998, Pages 297-303

  DeCoster, Mark A ^a   Mukherjee, Pranab K ^a   Davis, Roger J ^b   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

C Jun N terminal kinase; Neuronal survival; Neuroprotection; P38; Stress sensitive MAP kinases

Indexed keywords

EXCITATORY AMINO ACID; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; ENZYME ACTIVATION; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ASTROCYTES; AZEPINES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KAINIC ACID; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONAL PLASTICITY; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN KINASES; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; TRIAZOLES;

EID: 0032146827     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980801)53:3<297::AID-JNR3>3.0.CO;2-5     Document Type: Article

References (39)

1. Arai A, Lynch G (1992): Antagonists of the platelet-activating factor receptor block long-term potentiation in hippocampal slices. Euro J Neurosci 4:411-419.
2. Bading H, Greenberg ME (1991): Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253: 912-914.
3. Bazan HEP, Varner L (1997): A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet-activating factor (PAF) in corneal epithelium. Curr Eye Res 16:372-379.
4. Bazan NG (1995): Inflammation: A signal terminator. Nature 374:501-502.
5. Bazan NG (1997): Lipid messengers and prostaglandin endoperoxide synthase-2 in neuronal cell death. In "Primers in Cerebrovascular Diseases." M. Welsh, L Caplan, D Reis, B Siesjö, B Weir (eds), Academic Press, pp 193-195.
6. Bazan NG, Allan G (1998): Platelet-activating factor and other bioactive lipids. In "Cerebrovascular Disease, Pathophysiology, Diagnosis and Management." MD Ginsberg, J Bogousslavsky (eds), Chapter 37, Malden, Massachusetts: Blackwell Science Publishers, pp 532-555.
7. Bonaccorsi L, Luconi M, Maggi M, Muratori M, Forti G, Serio M, Baldi E (1997): Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. Biochim Biophys Acta 1355:155-166.
8. Choi DW, Maulucci-Gedde M, Kriegstein AR (1987): Glutamate neurotoxicity in cortical cell culture. J Neurosci 7:357-368.
9. Clark GD, Happel LT, Zorumski CF, Bazan NG (1992): Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9:1211-1216.
10. Creedon DJ, Johnson EM, Lawrence JC (1996): Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem 271:20713-20718.
11. DeCoster MA, Yourick DL (1994): Development of glutamate-stimulated phosphatidylinositol metabolism in primary neuronal and astrocyte cultures. Int J Dev Neurosci 12:227-233.
12. DeCoster MA, Hunter JC, Hughes J, and Tortella FC (1992): Effect of the selective kappa opioid agonist CI-977 on glutamate-induced LDH release from cultured rat neurons. Pharm Commun 1:5-11.
13. DeCoster MA, Klette KL, Knight ES, Tortella FC (1995): Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res 671:45-53.
14. English JD, Sweatt JD (1996): Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J Biol Chem 271:24329-24332.
15. Fiore RS, Murphy TH, Sanghera JS, Pelech SL, Baraban JM (1993): Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J Neurochem 61:1626-1633.
16. Fouda SI, Molski TF, Ashour MS, Sha'afi RI (1995): Effect of lipopolysaccharide on mitogen-activated protein kinases and cytosolic phospholipase A2. Biochem J 308:815-822.
17. Fox K, Daw N, Sato H, Czepita D (1991): Dark-rearing delays the loss of NMDA-receptor function in kitten visual cortex. Nature 350:342-344.
18. Gilboe DD, Kinter D, Fitzpatrick JH, Emoto SE, Esanu A, Braquet PG, Bazan NG (1991): Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists. J Neurochem 56:311-319.
19. Hibi M, Lin A, Smeal T, Minden A, Karin M (1993): Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135-48.
20. Honda Z, Takano T, Gotoh Y, Nishida E, Ito K, Shimizu T (1994): Transfected Platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J Biol Chem 269:2307-2315.
21. Kato K, Clark GD, Bazan NG, Zorumski CF (1994): Platelet-activating factor as a potential retrograde messenger in CAI hippocampal long-term potentiation. Nature 367:175-179.
22. Kleinschmidt A, Bear MF, Singer W (1987): Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex. Science 238:355-358.
23. Koh J-Y, Goldberg MP, Hartley DM, Choi DW (1990): Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci 10:693-705.
24. Kornecki E, Ehrlich YH (1988): Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science 240:1792-1794.
25. Kumar R, Harvey S, Kester N, Hanahan D, Olson M (1988): Production and effects of platelet-activating factor in the rat brain. Biochim Biophys Acta 963:375-383.
26. kurino M, Fukunaga K, Ushio Y, Miyamoto E (1995): Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J Neurochem 65:1282-1289.
27. Madison DV, Malenka RC, Nicoll RA (1991): Mechanisms underlying long term potentiation of synaptic transmission. Ann Rev Neurosci 14:379-397.
28. Marcheselli V, Bazan NG (1996): Sustained induction of prostaglandin endoperoxidase synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. J Biol Chem 271:24794-24799.
29. Mukherjee PK, DeCoster MA, Bazan NG (1995): Kainic acid-induced epileptogenesis increases mitogen activated protein kinase activity in hippocampus: Involvement of platelet-activating factor as a mediator. Epilepsia 36:26.
30. Nakanishi S (1992): Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603.
31. Nogami K, Hirashima Y, Endo S, Takaku A (1997): Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures. Brain Res 754:72-78.
32. Panetta T, Marcheselli VL, Braquet P, Spinnewyn B, Bazan NG (1987): Effects of a platelet-activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphospho inositides and blood in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury. Biochem Biophys Res Commun 149: 580-587.
33. Prehn JHM, Krieglstein J (1993): Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34:179-188.
34. Rabacchi S, Bailly Y, Delhaye-Bouchaud N, Mariani J (1992): Involvement of the NMDA receptor in synapse elimination during cerebellar development. Science 256:1823-1825.
35. Seeburg PH (1993): The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16:359-365.
36. Smith DB, Johnson KS (1988): Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
37. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995): Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
38. Wieraszko A, Li G, Kornecki E, Hogan MV, Ehrlich YH (1993): Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron 10:553-557.
39. Zivin JA, Choi DW (1991): Stroke therapy. Sci Am 265:56-63.